JP2021519600A5 - - Google Patents

Info

Publication number
JP2021519600A5
JP2021519600A5 JP2020554536A JP2020554536A JP2021519600A5 JP 2021519600 A5 JP2021519600 A5 JP 2021519600A5 JP 2020554536 A JP2020554536 A JP 2020554536A JP 2020554536 A JP2020554536 A JP 2020554536A JP 2021519600 A5 JP2021519600 A5 JP 2021519600A5
Authority
JP
Japan
Prior art keywords
influenza
ferritin
polypeptide
antigenic
polypeptide according
Prior art date
Application number
JP2020554536A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019195284A5 (https=
JP2021519600A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/025377 external-priority patent/WO2019195284A1/en
Publication of JP2021519600A publication Critical patent/JP2021519600A/ja
Publication of JPWO2019195284A5 publication Critical patent/JPWO2019195284A5/ja
Publication of JP2021519600A5 publication Critical patent/JP2021519600A5/ja
Priority to JP2024006461A priority Critical patent/JP2024041980A/ja
Pending legal-status Critical Current

Links

JP2020554536A 2018-04-03 2019-04-02 抗原性インフルエンザ−フェリチンポリペプチド Pending JP2021519600A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024006461A JP2024041980A (ja) 2018-04-03 2024-01-19 抗原性インフルエンザ－フェリチンポリペプチド

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862652204P 2018-04-03 2018-04-03
US62/652,204 2018-04-03
PCT/US2019/025377 WO2019195284A1 (en) 2018-04-03 2019-04-02 Antigenic influenza-ferritin polypeptides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024006461A Division JP2024041980A (ja) 2018-04-03 2024-01-19 抗原性インフルエンザ－フェリチンポリペプチド

Publications (3)

Publication Number Publication Date
JP2021519600A JP2021519600A (ja) 2021-08-12
JPWO2019195284A5 JPWO2019195284A5 (https=) 2022-04-07
JP2021519600A5 true JP2021519600A5 (https=) 2022-04-07

Family

ID=66175544

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020554536A Pending JP2021519600A (ja) 2018-04-03 2019-04-02 抗原性インフルエンザ−フェリチンポリペプチド
JP2024006461A Pending JP2024041980A (ja) 2018-04-03 2024-01-19 抗原性インフルエンザ－フェリチンポリペプチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024006461A Pending JP2024041980A (ja) 2018-04-03 2024-01-19 抗原性インフルエンザ－フェリチンポリペプチド

Country Status (4)

Country Link
EP (1) EP3773703A1 (https=)
JP (2) JP2021519600A (https=)
CN (1) CN112512565A (https=)
WO (1) WO2019195284A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112512566A (zh) 2018-04-03 2021-03-16 赛诺菲 抗原性爱泼斯坦-巴尔病毒多肽
BR112020019938A2 (pt) 2018-04-03 2021-01-26 Sanofi polipeptídeos antigênicos de vírus sincicial respiratório
CN112512564A (zh) 2018-04-03 2021-03-16 赛诺菲 铁蛋白蛋白
BR112022021208A8 (pt) * 2020-04-22 2023-02-23 Medicago Inc Supraestrutura compreendendo hemaglutinina de influenza modificada com interação reduzida com ácido siálico
WO2021231729A1 (en) * 2020-05-13 2021-11-18 Sanofi Adjuvanted stabilized stem hemagglutinin nanoparticles and methods of using the same to induce broadly neutralizing antibodies against influenza
US20240165224A1 (en) * 2021-03-26 2024-05-23 Glaxosmithkline Biologicals Sa Immunogenic compositions

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE509102T1 (de) 1994-07-15 2011-05-15 Univ Iowa Res Found Immunomodulatorische oligonukleotide
US6239116B1 (en) 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6429199B1 (en) 1994-07-15 2002-08-06 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules for activating dendritic cells
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
WO1998037919A1 (en) 1997-02-28 1998-09-03 University Of Iowa Research Foundation USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS
US6406705B1 (en) 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
AU7690898A (en) 1997-05-20 1998-12-11 Ottawa Civic Hospital Loeb Research Institute Vectors and methods for immunization or therapeutic protocols
ATE356630T1 (de) 1998-04-03 2007-04-15 Univ Iowa Res Found Verfahren und produkte zur stimulierung des immunsystems mittels immunotherapeutischer oligonukleotide und zytokine
WO2001075436A1 (en) 2000-04-03 2001-10-11 Board Of Trustees Of The Leland Stanford Junior University A method for protein structure alignment
US7774185B2 (en) 2004-09-14 2010-08-10 International Business Machines Corporation Protein structure alignment using cellular automata
JP5795184B2 (ja) * 2011-04-22 2015-10-14 国立大学法人 奈良先端科学技術大学院大学 被検物質の電気化学的検出方法
EP2515112B1 (en) * 2011-04-22 2015-08-12 Sysmex Corporation Method for electrochemically detecting analyte
US9580475B2 (en) 2011-06-20 2017-02-28 University of Pittsburgh—of the Commonwealth System of Higher Education Computationally optimized broadly reactive antigens for H1N1 influenza
CA2849822C (en) * 2011-09-23 2021-05-11 Gary J. Nabel, M.D. Novel influenza hemagglutinin protein-based vaccines
RU2639551C2 (ru) 2012-03-30 2017-12-21 Юниверсити Оф Питтсбург - Оф Зе Коммонвэлс Систем Оф Хайе Эдьюкейшн Оптимизированные с помощью вычислительных средств антигены с широким спектром реактивности для вирусов гриппа h5n1 и h1n1
FI2970398T3 (fi) * 2013-03-13 2024-08-06 Us Health Rsv f -prefuusioproteiineja ja niiden käyttö
CA2950085A1 (en) * 2014-05-27 2015-12-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Stabilized influenza hemagglutinin stem region trimers and uses thereof
US9703095B2 (en) 2015-01-05 2017-07-11 Edward Pakhchyan Light modulator for MEMS display
FI3471760T3 (fi) 2016-06-17 2025-01-27 Boehringer Ingelheim Vetmedica Gmbh Lineaarisia tai haaroittuneita polyakryylihappopolymeeriadjuvantteja käsittäviä uusia immunogeenisiä formulaatioita

Similar Documents

Publication Publication Date Title
JP2021519600A5 (https=)
US11793871B2 (en) Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereof
Jegerlehner et al. A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses
Laver et al. Antigenic drift in type A influenza virus: sequence differences in the hemagglutinin of Hong Kong (H3N2) variants selected with monoclonal hybridoma antibodies
JP7298046B2 (ja) インフルエンザヘマグルチニンタンパク質およびその方法
Deliyannis et al. Induction of long-term memory CD8+ T cells for recall of viral clearing responses against influenza virus
Mardanova et al. Rapid high-yield expression of a candidate influenza vaccine based on the ectodomain of M2 protein linked to flagellin in plants using viral vectors
JP2016199557A5 (https=)
CN107488218B (zh) 一种多肽、免疫原性偶联物和流感疫苗
JP2016534070A (ja) 安定化ワクチンの製造のための新規方法
JP2018504412A5 (https=)
WO2007011904A3 (en) Recombinant flu vaccines
EA202192921A1 (ru) Рекомбинантные антигены вируса гриппа
JP2019214579A5 (https=)
CN101227919B (zh) 基于肽的流感疫苗制剂
JP2010508030A5 (https=)
JPWO2019195284A5 (https=)
RU2019113989A (ru) Лекарственное средство
JP2018501258A5 (https=)
US10286062B2 (en) Universal influenza vaccine
US20180244724A1 (en) Polypeptide compound and preparation method and use thereof
JP2019534242A5 (https=)
Lim et al. RNA-dependent assembly of chimeric antigen nanoparticles as an efficient H5N1 pre-pandemic vaccine platform
CN107522777B (zh) 用于预防或治疗流感病毒的多肽、免疫原性偶联物及用途
WO2013072946A1 (en) Lactoferrin derived peptides for use as broad- spectrum inhibitors of influenza virus infection